Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

NETWORK 3OTHER 2NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Lymphoid 1

Conditions

Multiple Myeloma 49Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Burkitt Lymphoma 12Lymphoma, Mantle-Cell 6Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myeloid, Acute 5Neoplasm Metastasis 4Leukemia 4Immunoglobulin Light-chain Amyloidosis 4Breast Neoplasms 4Blast Crisis 4Vomiting 3Smoldering Multiple Myeloma 3Myelodysplastic Syndromes 3Lymphoma 3Leukemia, Myelomonocytic, Chronic 3Hodgkin Disease 3Hematologic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmacytoma 2Ovarian Neoplasms 2Neoplasms, Plasma Cell 2Neoplasms 2Nausea 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2

Interventions

Cyclophosphamide 37fludarabine phosphate 27Whole-Body Irradiation 26Cytarabine 26Mycophenolic Acid 22Methotrexate 20Filgrastim 19Peripheral Blood Stem Cell Transplantation 18Cyclosporine 18fludarabine 17venetoclax 15Busulfan 13Tacrolimus 12Granulocyte Colony-Stimulating Factor 12Cord Blood Stem Cell Transplantation 12Thiotepa 11Antilymphocyte Serum 11Melphalan 10Azacitidine 10Dexamethasone 9Cladribine 9Vincristine 8Specimen Handling 8Radiotherapy 8Mitoxantrone 8Methylprednisolone 8Idarubicin 7Cyclosporins 7Clofarabine 7Hydrocortisone 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Leukemia, Biphenotypic, Acute × dexamethasone 21-phosphate × Clear all
NCT05292664 2026-03-12

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Dana-Farber Cancer Institute

Phase 1 Recruiting
30 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Neoplasm Metastasis, Recurrence, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02135874 2024-03-22

Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia

M.D. Anderson Cancer Center

Phase 2 Completed
16 enrolled 9 charts
Other hematologic neoplasm

Leukemia, Biphenotypic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡